Skip to main navigation menu Skip to main content Skip to site footer
Plant Science Today (PST)

Review Articles

Vol. 12 No. 1 (2025)

Exploring the hidden treasures of Coptis teeta Wall.: Ethnomedicinal claims, traditional wisdom and promising avenues for research

DOI
https://doi.org/10.14719/pst.4308
Submitted
10 July 2024
Published
10-12-2024 — Updated on 01-01-2025
Versions

Abstract

Coptis teeta Wall., commonly known as Mishmi teeta, is a perennial herbaceous plant belonging to the Ranunculaceae family and is rich in various bioactive compounds. It is classified as endangered on the Red List and is endemic to the Eastern Himalayas in Northeast India, representing a valuable repository of traditional wisdom and ethno medicinal practices. This article compiles available data on C. teeta for the first time, drawing from classical Ayurveda texts, botanical floras and research databases. Since 3000 B.C., this "Goldthread" has been an integral part of Traditional Chinese Medicine (TCM) as Rhizoma coptidis. Through an extensive literature search, including online published reviews, research articles, and ethnomedicinal survey reports, it has been found that various tribes in Arunachal Pradesh, India, have utilized its potent therapeutic benefits for centuries to treat ailments such as gastrointestinal disorders, malaria, diabetes, eye disorders, infectious diseases, and more. The vivid pharmacological activities of C. teeta are primarily attributed to its alkaloids and other non-alkaloidal components, although limited preclinical work has been reported to date. The roots and rhizomes of C. teeta are rich in alkaloids such as berberine, jatrorrhizine, columbamine, epiberberine, coptisine and palmatine. These compounds play a significant therapeutic role in managing various ailments, including diabetes and cardiovascular diseases. They possess anti- inflammatory and analgesic properties, offer neuroprotective effects, aid in metabolic regulation and exhibit antimicrobial activity. Additionally, this review discusses the extensive trade benefits of C. teeta, the reasons for its threatened status, and various practical approaches for its conservation and cultivation. By bridging ethnomedicinal knowledge with scientific modernization through a multidisciplinary research approach, this review aims to unlock the hidden treasures of C. teeta and encourage further pharmacological research and standardization.

References

  1. Mukherjee P. Evaluation of Indian traditional medicine. Drug Inf J. 2001;2:623. https://doi.org/10.1177/009286150103500235
  2. Jaiswal YS, Williams LL. A glimpse of Ayurveda–The forgotten history and principles of Indian traditional medicine. J Tradit Complement Med. 2017;7(1):50-3. https://doi.org/10.1016/j.jtcme.2016.02.00211 Plant Science Today, ISSN 2348-1900 (online)
  3. Balunas MJ, Kinghorn AD. Drug discovery from medicinal plants. Life Sci. 2005;78(5):431-41. https://doi.org/10.1016/j.lfs.2005.09.012
  4. World Health Organization. WHO global report on traditional and complementary medicine 2019. World Health Organization; 2019 May 16.
  5. Khajuria AK, Manhas RK, Kumar H, Bisht NS. Ethnobotanical study of traditionally used medicinal plants of Pauri district of Uttarakhand, India. J Ethnopharmacol 2021;276:114204. https://doi.org/10.1016/j.jep.2021.114204
  6. Hu R, Lin C, Xu W, Long C. Ethnobotanical study on medicinal plants used by Mulam people in Guangxi, China. J Ethnobiol Ethnomed 2020;16:40. https://doi.org/10.1186/s13002-020-00387-z
  7. Sarma DK, Mohapatra PK, Bhattacharyya DR, Chellappan S, et al. Malaria in North-East India: importance and implications in the era of elimination. Microorganisms. 2019;7(12):673. https://doi.org/10.3390/microorganisms7120673
  8. Sajem AL, Gosai K. Traditional use of medicinal plants by the Jaintia tribes in North Cachar Hills district of Assam, northeast India. J Ethnobiol Ethnomed. 2006;2(1):1-7. https://doi.org/10.1186/1746-4269-2-33
  9. Haridasan K, Anupam Sarmah AS, Bhuyan LR, Bisht NS. Medicinal plants sector in Arunachal Pradesh-an overview. The Indian Forester. 2003;1(129):1-11.
  10. Khongsai M, Saikia SP, Kayang H. Ethnomedicinal plants used by different tribes of Arunachal Pradesh. IJTK. 2011;10(3):541-46.
  11. Das AK, Tag H. Ethnomedicinal studies of the Khamti tribe of Arunachal Pradesh. IJTK. 2006;5(3):317-22.
  12. Kanjilal and Borthakur: Flora of Assam, Reprint edition, Omsons Publications, New Delhi. 1997;1:9.1100270.
  13. Chauhan A, Goyal MK, Chauhan P. GC-MS Technique and its Analytical Applica­tions in Science and Technology. J Anal Bioanalytical Tech. 2014;5(6):222. https://doi.org/10.4172/2155-9872.1000222
  14. Payum T. Distribution, Ethnobotany, Pharmacognosy and Phytoconstituents of Coptis teeta Wall.: A Highly Valued and Threatened Medicinal Plant of Eastern Himalayas. Pharmacogn J. 2017;9(6):s28-s34. https://doi.org/10.5530/pj.2017.6s.154
  15. Flora of China Committee of Chinese Academy of Sciences. 2004. Flora of China. Vol. 27. Beijing: Science Press; p. 593.
  16. Ran Q, Huang QW. Rhizoma coptidis as a potential treatment agent for type 2 diabetes mellitus and the underlying mechanisms: a review. Front Pharmacol. 2019;10:434868. https://doi.org/10.3389/fphar.2019.00805
  17. Guo M, Liu Y, Gao ZY, Shi DZ. Chinese herbal medicine on dyslipidemia: progress and perspective. J Evid Based Complementary Altern Med. 2014;2014(1):163036. https://doi.org/10.1155/2014/163036
  18. Wang J, Wang L, Lou GH, Zeng HR, et al. Coptidis rhizoma: a comprehensive review of its traditional uses, botany, phytochemistry, pharmacology and toxicology. Pharm Biol. 2019;57(1):193–225. https://doi.org/10.1080/13880209.2019.1577466
  19. Huang J, Long C. "Coptis teeta-based agroforestry system and its conservation potential: A case study from northwest Yunnan". Ambio. 2007;36(4):343-49. https://doi.org/10.1579/0044-7447(2007)36[343:ctasai]2.0.co;2
  20. Professor KC Chunekar, commentator. Bhavpraksha Nighantu (Indian Materia Medica), edited by; Late Dr. GS. Pandey, Parishista 1, Chaukhambha Bharati Academy, Varanasi (India), 2013;809-810.
  21. Bapalal Vaidya. Nighantu Adarsa. Vol. 1. Ch.1. Vatsnabhadi Varga, Chaukhambha Bharati Academy, Varanasi (India), 2007;19-21.
  22. Dr. Kamat SD., editor. Studies on Medicinal plants and Drugs in Saraswati Nighantu, Candanadi vargah, Chaukhamba Sanskrit Pratishthan, Delhi, 2006; 97.
  23. Hooker JD. Flora of British India. Part I. Ranunculaceae to Polygalae. London: Covent Garden; 1872:22-23.
  24. Rastogi RP, editor. Compendium of Indian Medicinal Plants. Vol. 5.1990-1994. Central Drug Research Institute, Lucknow and National Institute of Science Communication, New Delhi, 1998:246.
  25. Chopra RN, Nayar SL, Chopra IC. Glossary of Indian Medicinal Plants, NISCAIR Press, National Institute of Science Communication and Information Resources, (CSIR), New Delhi, 2006: 76.
  26. Kirtikar KR and Basu BD. Indian Medicinal Plants. Vol.1. Phanerogamia. Ranunculaceae, Jayyed Press, Delhi, 1975: 19.
  27. Saxena HO, Brahmam M. The Flora of Orissa. Vol. I. Ranunculaceae to Fabaceae. Orissa Forest Development Corporation Ltd. Bhubaneswar, 1994.
  28. Lawrence GHM. Taxonomy of Vascular Plants, Oxford & IBH Publishing Co. Pvt. Ltd., New Delhi, 1967: 496.
  29. Central Council for Research in Ayurvedic Sciences (CCRAS). Mamira (Coptis teeta Wall) [Internet]. New Delhi: CCRAS; [cited 2024 Jun 28]. Available from: http://ccras.nic.in/content/mamiracoptis-teeta-wall
  30. The Wealth of India. A Dictionary of Indian Raw materials & Industrial Products. First Supplement Series (Raw Materials). Vol.2: Cl-Cy, National Institute of Science Communication and Information Resources, New Delhi, India, 2004: 174-175.
  31. Doh EJ, Lee MY, Ko BS, Oh SE Differentiating Coptis chinensis from Coptis japonica and other Coptis species used in Coptidis Rhizoma based on partial trnL-F intergenic spacer sequences. Genes Genom 2014;36:345-54. https://doi.org/10.1007/s13258-014-0172-2
  32. Kamath S, Skeels M, Pai A. Significant differences in alkaloid content of Coptis chinensis (Huanglian), from its related American species. Chin Med 2009;4(17):1-4. https://doi.org/10.1186/1749-8546-4-17
  33. Kou S, Han B, Wang Y, Huang T, He K, Han Y, et al. Synergetic cholesterol-lowering effects of main alkaloids from Rhizoma Coptidis in HepG2 cells and hypercholesterolemia hamsters. Life Sci. 2016;151:50-60. https://doi.org/10.1016/j.lfs.2016.02.046
  34. Weng SW, Chen BC, Wang YC, Liu CK, et al. Traditional Chinese medicine use among patients with psoriasis in Taiwan: a nationwide population-based study. J Evid Based Complementary Altern Med. 2016;2016(1):3164105. https://doi.org/10.1155/2016/3164105
  35. Hung TM, Lee JP, Min BS, Choi JS, Na M, Zhang X, et al. Magnoflorine from Coptidis Rhizoma protects high density lipoprotein during oxidant stress. Biol Pharm Bull. 2007;30:1157–160. https://doi.org/10.1248/bpb.30.1157
  36. Qiao YL, Sheng YX, Wang LA, Zhang JL. Development of a rapid resolution liquid chromatographic method for simultaneous analysis of four alkaloids in Rhizoma Coptidis under different cultivation conditions. J AOAC Int 2009;92:663-71. https://doi.org/10.1093/jaoac/92.2.663
  37. Wu S, Xu L, Liu H, Tong X. Clinical application and dosage of Coptidis Rhizoma. Chin Clin Doctor. 2015;43:92-4. https://doi.org/10.1080%2F13880209.2019.1577466
  38. Schippmann U, Leaman DJ, Cunningham AB. A comparison of cultivation and wild collection of medicinal and aromatic plants under sustainability aspects. Front Ecol Environ. 2006;4(6):272-79. https://doi.org/10.1007/1-4020-5449-1_6
  39. Kala CP. Indigenous uses, population density, and conservation of threatened medicinal plants in protected areas of the Indian VAIDEHI ET AL 12 https://plantsciencetoday.online Himalayas. Conserv Biol. 2005;19(2):368-78. https://doi.org/10.1111/j.1523-1739.2005.00602.x
  40. Gupta R, Gupta J. Rare and Endangered Plant Species with Potential Remedial Outcomes of Coptis teeta: An Updated Review. Bull Env Pharmacol Life Sci. 2020;9:1-5.
  41. Ji Huang and Chunlin Long Coptis teeta-based Agroforestry System and Its Conservation Potential: A Case Study from Northwest Yunnan. AMBIO 2007;36(4):343-49. https://doi.org/10.1579/0044-7447(2007)36[343:ctasai]2.0.co;2
  42. Mukherjee D, Chakraborty S. Coptis Teeta: conservation and cultivation practice-A rare medicinal plant on Earth. Curr Invest Agric Curr Res. 2019;6:845-51. https://doi.org/10.32474/ciacr.2019.06.000244
  43. Bhattee SS, Beniwal BS. Coptis teeta Wall. - an Important and Valuable Medicinal Plant of Arunachal Pradesh and its Cultivation. The Indian Forester. 1988;114:251-60.
  44. Bajpay A, Nainwal RC, Singh D. Coptis teeta: a potential endemic and endangered medicinal plant of Eastern Himalayas. J Pharmacogn Phytochem 2019;8(4):245-48. https://doi.org/10.14218/FIM.2023
  45. Yang YanJuan YY, Xie ShiQing XS, Meng ZhenGui MZ, Chen GuangMing CG, Liang YanLi LY. Pollination ecology of Coptis teeta Wall. an endangered medicinal plant. Boreal.- Occident. Sin. 2012;32(7):1372-76.
  46. Xiang KL, Wu SD, Yu SX, Liu Y, et al. The first comprehensive phylogeny of Coptis (Ranunculaceae) and its implications for character evolution and classification. PLoS One. 2016;11(4):e0153127. https://doi.org/10.1371/journal.pone.0153127
  47. Molony D. Complete guide to Chinese herbal medicine. New York: Berkeley Books; 1998.
  48. Latif A, Razique A, Asadullah RS, Zuberi RH. Phytochemical and Physico-chemical study of Coptis teeta Wall.: An effective drug of choice in ocular ailments. Eur J Integr Med. 2008;1:22-3. https://doi.org/10.1016/j.eujim.2008.08.128
  49. Namboothiri DG, Remya P, Bijeshmon PP. Pharmacognostic evaluation of the rhizome of Coptis teeta Wall. IJRAP. 2014;5(4):402-5. https://doi.org/10.7897/2277-4343.05483
  50. Hao DC, Ge GB, Xiao PG, Wang P, Yang L. Drug metabolism and pharmacokinetic diversity of ranunculaceae medicinal compounds. Curr Drug Metab. 2015;16(4):294-321. https://doi.org/10.2174/1389200216666150803144631
  51. Chelleng N, Sonia H, Tamuly C. Coptis teeta Wall.: A Comprehensive Overview of its Traditional Uses, Pharmacological Uses, Phytochemicals and Conservation. FIM. 2024;3(1):21-34. https://doi.org/10.14218/fim.2023.00082
  52. Huang P, Qian X, Li J, Cui X, Chen L, Cai B, Tan S. Simultaneous determination of 11 alkaloids in crude and wine-processed Rhizoma Coptidis by HPLC-PAD. J Chromatogr Sci. 2015;53(1):73-78. https://doi.org/10.1093/chromsci/bmu019
  53. Shwe KT. Investigation of Antimicrobial Activity, Elemental Analysis and Isolation of organic compounds of Coptis teeta Wall. (Hkantauk). Dagon University Commemoration of 25th Anniversary Silver Jubilee Research Journal 2019;9(2):28-33.
  54. Bora H, Kamle M, Chopra S, Kumar P. Evaluation of Phytochemical Components, Antioxidant, and Antibacterial Activities of Coptis teeta Walls. IJPRAS. 2022;11(4-2022):140-150. https://doi.org/10.51847/1jgpbykz1k
  55. Li D, Zhou L, Wang Q, He Y. Determination of organic acids for quality evaluation in Coptis herbs by ion chromatography. Biotech. 2018;8(6):1-6. https://doi.org/10.1007/s13205-018-1300-5
  56. Meng F, Wang L, Zhang J, Yin Z, et al. Non-alkaloid chemical constituents from the rhizome of Coptis teeta. J China Pharmaceut Univ. 2013;44(4):307-10. http://dx.doi.org/10.11665/j.issn.1000-5048.20130404
  57. Perrins JD. XLIII.-On berberine-contributions to its history and revision of its formula. J Chem Soc. 1862;15:339–56. https://doi.org/10.1039/js8621500339
  58. Babbar OP, Chhatwal VK, Ray IB, Mehra MK. Effect of berberine chloride eye drops on clinically positive trachoma patients. Indian J Med Res. 1982;76:83-8. https://imsear.searo.who.int/handle/123456789/19526
  59. Lone TA, Rahul M, Lone RA. In vitro anti-oxidant studies by using different methods and evaluation of anti-microbial potential of Coptis teeta. GJBB. 2014;9(4):99-104. https://10.5829/idosi.gjbb.2014.9.4.91138
  60. Goswami AK, Gogoi N, Shakya A, Sharma HK. Development and validation of high-performance thin-layer chromatographic method for quantification of berberine in rhizomes of Coptis teeta wall, an endangered species collected from arunachal pradesh, India. J Chromatogr Sci. 2019;57(5):411-417. https://doi.org/10.1093/chromsci/bmz009
  61. Chondhe M, Hande S, Singh S. Evaluation and validation of stability indicating RP-HPLC method for the use of Berberine from Coptis teeta bark as anti-cancer phytochemical. AJPCR 2021;4(14):1-5. https://doi.org/10.22159/ajpcr.2021.v14i4.40400
  62. Mihin D, Choudhury D. Eco-cultural heritage of Arunachal Pradesh In: Proc Natl Seminar Interpreting the Heritage of North East, India (INTACH, New Delhi); 2006; 42-59.
  63. Kagyung R, Gajurel PR, Rethy P, Singh B. Ethnomedicinal plants used for gastro-intestinal diseases by Adi tribes of DehangDebang Biosphere Reserve in Arunachal Pradesh. IJTK 2010;9(3):496-501.
  64. Srivastava RC. Traditional knowledge of Adi tribe of Arunachal Pradesh on plants. IJTK 2009;8(2):146-53.
  65. Perme N, Choudhury SN, Choudhury R, Natung T, De B. Medicinal plants in traditional use at Arunachal Pradesh, India. Int J Phytopharm. 2015;5(5):86-98.
  66. Ghosh G. Role of Plant bioresources in Traditional Health care system: A case study from the Upper Siang District of Arunachal Pradesh, India. Indian J Appl Pure Biol. 2021;2(1):241-49.
  67. Choudhary RK and Srivastava RC. IPR and traditional knowledge of Adi, Memba & Khamba tribes of Upper Siang District (Arunachal Pradesh). Botanical survey of India, Itanagar – 791 111. Intellectual Property rights (Plant Varieties and Genome Conservation) 2006;1-9.
  68. Baruah S, Borthakur SK, Gogoi P, Ahmed M. Ethnomedicinal plants used by Adi-Minyong tribe of Arunachal Pradesh, eastern Himalaya. IJTK 2013;4(3):278-82.
  69. Shankar R, Rawat MS. Medicinal plants used in traditional medicine in Lohit and Dibang valley districts of Arunachal Pradesh. IJTK 2008;7(2):288-95.
  70. Tangjang S, Namsa ND, Aran C, Litin A. An ethnobotanical survey of medicinal plants in the Eastern Himalayan zone of Arunachal Pradesh, India. J Ethnopharmacol. 2011;134(1):18-25. https://doi.org/10.1016/j.jep.2010.11.053
  71. Ali N, Ghosh B. Ethnomedicinal plants in Arunachal Pradesh: Some tacit prospects. ENVIS Bull Himalayan Eco. 2006;14(2):22-7.
  72. Moushumi D, Anju J, Hirendra SN. Traditional medicines of herbal origin practice by the Adi tribe of East Siang district of Arunachal Pradesh, India. GJRMI. 2013;2(5):298.
  73. Rethy P, Singh B, Kagyung R, Gajurel PR. Ethnobotanical studies of Dehang-Debang Biosphere Reserve of Arunachal Pradesh with special reference to Memba tribe. IJTK. 2008;7(2):288-95.
  74. Barbhuiya PA, Laskar AM, Mazumdar H, Dutta PP, et al. Ethnomedicinal practices and traditional medicinal plants of Barak Valley, Assam: a systematic review. JoP. 2022;25(3):149. https://doi.org/10.3831/kpi.2022.25.3.14913 Plant Science Today, ISSN 2348-1900 (online)
  75. Choudhury MD, Bawari M, Singha LS. Some antipyretic ethnomedicinal plants of Manipuri community of Barak Valley, Assam, India. Ethnobot Leafl. 2010;14:21-8.
  76. Tripathi AK, Limasenla RS, Tewari D. Nutritional Assessment of Some Important Medicinal Plants Used by Nyishi Tribes of Arunachal Pradesh. Fazl Ali College Journal 2017;7:70-75.
  77. Saikia S, Begum RA, Buragohain A. Comprehensive list of antimalarial plants used by different communities of Assam and Arunachal Pradesh, India. Int J Mosq Res. 2021;8:63-69. https://doi.org/10.22271/23487941.2021.v8.i2a.540
  78. Ahmad SR, Tamang M. Study of indigenous medicinal plants of northeast states of India as potential therapies for Malaria. Biosci Biotechnol Res Asia. 2020;17(3):567. https://doi.org/10.13005/bbra/2860
  79. Tag H, Kalita P, Dwivedi P, Das AK, Namsa ND. Herbal medicines used in the treatment of diabetes mellitus in Arunachal Himalaya, northeast, India. J Ethnopharmacol. 2012;141(3):786-95. https://doi.org/10.1016/j.jep.2012.03.007
  80. Ramya Tarh DT, John SS. Ethnomedicinal Practices among Adis in Two Villages of Upper Siang District, Arunachal Pradesh. Dera Natung Government College Research Journal. 2021:2456-8228. https://doi.org/10.56405/dngcrj.2021.06.01.01
  81. Zhang D, Arunachalam K, Wang Y, et al. Evaluation on antidiabetic properties of medicinal plants from Myanmar. Sci World J. 2021;2021(1). https://doi.org/10.1155/2021/1424675
  82. Goswami AK, Sharma HK, Shakya A. Evaluation of analgesic and anti-inflammatory activity of standardized methanolic extract of Coptis teeta (Wall.) rhizomes. Curr Trends Pharm Res. 2017;4:1-5.
  83. Ren Y, Wang Z, Wu C, Dong H, et al. Ultrahigh-performance liquid chromatography with tandem mass spectrometry for the determination of 10 alkaloids in beagle plasma after the oral administration of the three Coptidis rhizoma extracts. J Ethnopharmacol. 2019;239:111896. https://doi.org/10.1016/j.jep.2019.111896
  84. Liu LM, Liu J, Huang ZX, Yu XX, Zhang XY, Dou D, et al. Berberine improves endothelial function by inhibiting endoplasmic reticulum stress in the carotid arteries of spontaneously hypertensive rats. Biochem Biophys Res Commun 2015;458(4):796-801. https://doi.org/10.1016/j.bbrc.2015.02.028
  85. Guo ZT, Sun HR, Zhang HM, Zhang YF. Anti-hypertensive and renoprotective effects of berberine in spontaneously hypertensive rats. Clin Exp Hypertens 2015;37(4):332-9. https://doi.org/10.3109/10641963.2014.972560
  86. Eaker EY, Sninsky CA. Effect of berberine on myoelectric activity and transit of the small intestine in rats. Gastroenterology 1989;96(6):1506-13. https://doi.org/10.1016/0016-5085(89)90519-2
  87. Lee B, Sur B, Yeom M, Shim I, et al. Effect of berberine on depression- and anxiety-like behaviors and activation of the noradrenergic system induced by development of morphine dependence in rats. Korean J Physiol Pharmacol 2012;16(6):379-86. https://doi.org/10.4196/kjpp.2012.16.6.379
  88. Kulkarni SK, Dhir A. Current investigational drugs for major depression. Expert Opin Investig Drugs 2009;18(6):767-88. https://doi.org/10.1517/13543780902880850
  89. Kong WJ, Wei J, Abidi P, Lin MH, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004;10(12):1344-51. https://doi.org/10.1038/nm1135
  90. Tan Y, Tang Q, Hu BR, Xiang JZ. Antioxidant properties of berberine on cultured rabbit corpus cavernosum smooth muscle cells injured by hydrogen peroxide. Acta Pharmacol Sin 2007;28(12):1914-18. https://doi.org/10.1111/j.1745-7254.2007.00705.x
  91. Khosla PK, Neeraj VI, Gupta SK, Satpathy G. Berberine, a potential drug for trachoma. Rev Int Trach Pathol Ocul Trop Subtrop Sante Publique 1992;69:147-65. PMID: 1344968.
  92. Moon M, Huh E, Lee W, Song EJ, Hwang DS, Lee TH. Coptidis Rhizoma Prevents Heat Stress-Induced Brain Damage and Cognitive Impairment in Mice. Nutrients 2017;9(10):1057. https://doi.org/10.3390/nu9101057
  93. Ni YX, Liu AQ, Gao YF, Wang WW, Song YG, Wang LH. Therapeutic Effect of Berberine on 60 Patients with Non-Insulin Dependent Diabetes Mellitus and Experimental Research. CJIM 1995;1:91–5. https://doi.org/10.1007/bf02942756
  94. Yin J, Xing HL, Ye JP. Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism 2008;57(5):712-7. https://doi.org/10.1016/j.metabol.2008.01.013
  95. Chit K, Myint W, Thein K, Maw WW, et al. Cyclic AMP Phosphodiesterase Inhibitory Activity and Chemical Screening of Four Medicinal Plants. Pharm Biol 2001;39(3):181-3. https://doi.org/10.1076/phbi.39.3.181.5932
  96. Abdul L, Abdul R, Sukul RR, Nazish S. Anti-inflammatory and Antihistaminic Study of a Unani Eye Drop Formulation. Ophthalmol Eye Dis 2010;2:17-22. https://doi.org/10.4137/oed.s3612
  97. Lau CW, Yao XQ, Chen ZY, Ko WH, Huang Y. Cardiovascular actions of berberine. Cardiovasc Drug Rev 2001;19(3):234-44. https://doi.org/10.1111/j.1527-3466.2001.tb00068.x
  98. Bora H, Kamle M, Hassan H, Al-Emam A, et al N. Exploration of Potent Antiviral Phytomedicines from Lauraceae Family Plants against SARS-CoV-2 Main Protease. Viruses 2022;14(12):2783. https://doi.org/10.3390/v14122783
  99. UNEP-WCMC (Comps). Checklist of CITES species. CITES Secretariat, Geneva, Switzerland and UNEP-WCMC, Cambridge, United Kingdom. 2014.
  100. Chandra LD. Bio-diversity and conservation of medicinal and aromatic plants. Adv Plants Agric Res. 2016;5(4):00186. https://doi.org/10.15406/apar.2016.05.00186
  101. Gowthami R, Sharma N, Pandey R, Agrawal A. Status and consolidated list of threatened medicinal plants of India. Genetic Resources and Crop Evolution. 2021 Aug;68(6):2235-63. https://doi.org/10.1007/s10722-021-01199-0
  102. Pandit MK, Babu CR. Biology and conservation of Coptis teeta Wall. - an endemic and endangered medicinal herb of Eastern Himalaya". Environ Conserv J. 1998;25(3):262-72. https://doi.org/10.1017/s0376892998000320
  103. Huang J, Long C. Traditional cultivation of Coptis teeta and its values in biodiversity con-servation". Biodiver Sci. 2006;14(1):79-86. https://doi.org/10.1360/biodiv.050092
  104. Kanjilal and Borthakur: Flora of Assam: (1997 reprint); Omsons Publications, New Delhi. 1997;1:9.1100270.
  105. Williamson N. The Lohit- Brahmaputra between Assam and South-Eastern Tibet, November 1907-January 1908. Geogr J. 1909;34(4):363-83. https://doi.org/10.2307/1777190
  106. Aiyadurai A. Meyors of Arunachal Pradesh. East Anthropol. 2011;64(4):459-69.
  107. Bisht NS, Bankoti TS. Encyclopaedic Ethnography of the Himalayan Tribes. 2004; Global vision Publishing House, Delhi 110093

Downloads

Download data is not yet available.